Mylan launches Takeda generic — 3 insights

Mylan launched a generic version of Takeda’s Prevacid to boost its gastroenterology portfolio, R&D reports.

Advertisement

Here’s what you should know:

1. The generic drug comes in 15 milligram and 30 milligram tablets.

2. The FDA approved Mylan’s abbreviated new drug application, which had the same indications as Takeda’s Prevacid.

3. The drug treats active stomach and small intestine ulcers, gastroesophageal reflux disease and Zollinger-Ellison syndrome.

More articles on gastroenterology:
Federal agencies target CON laws in Trump administration plan for healthcare reform — 4 insights
Aurora BayCare Medical Center has plans for ASC, clinic facility on 17-acre site — 3 notes
108 statistics to know on common ASC, outpatient services

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.